- Tytuł:
- A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors.
- Autorzy:
- Źródło:
- Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5).
- Typ publikacji:
- Clinical Trial, Phase I; Journal Article
- MeSH Terms:
-
Nivolumab*/adverse effects
Triple Negative Breast Neoplasms*/drug therapy
Humans ; Clinical Trials, Phase II as Topic ; Fever ; Protein Kinase Inhibitors ; Female
Czasopismo naukowe